Status:
COMPLETED
Empowerment Intervention for Young Women - Phase I
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
National Institute of Mental Health (NIMH)
Conditions:
HIV
Empowerment
Eligibility:
FEMALE
16-24 years
Phase:
NA
Brief Summary
This study will begin to develop a culturally appropriate secondary prevention intervention for young HIV+ women through focus groups. Using three intervention sites, focus groups will guide the deve...
Detailed Description
This study will develop/adapt a culturally appropriate secondary prevention intervention for young HIV+ women through focus groups. Using three intervention sites, focus groups will guide the developm...
Eligibility Criteria
Inclusion
- Female at birth and currently female;
- Receives services at one of the selected ATN sites or their community partners;
- HIV-infected as documented by medical record review or verbal verification with referring professional;
- Between the ages of 16-24 (inclusive) at the time of informed consent/assent;
- Ability to understand both written and spoken English; and
- Gives informed consent/assent for study participation.
Exclusion
- Presence of active, serious psychiatric symptoms (hallucinations, thought disorder) that would impair a participant's ability to meet the study requirements;
- Visibly distraught (suicidal, homicidal, exhibiting violent behavior);
- If other serious conditions are present during screening, the Protocol Team must be consulted to determine whether enrollment may interfere with the evaluation of the protocol objectives and for permission to proceed with the enrollment; or
- Intoxicated or under the influence of alcohol or other substances at the time of study enrollment\*.
- Participants cannot be visibly under the influence at the time of consent, enrollment, or during the focus group. Intoxication at the time of the focus group will exclude participation.
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2013
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT00891358
Start Date
November 1 2008
End Date
April 1 2013
Last Update
March 6 2017
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
USF College of Medicine
Tampa, Florida, United States, 33606
2
Ruth M Rothstein CORE Center/ John H Stroger Jr Hospital
Chicago, Illinois, United States, 60612
3
University of Maryland Medical School
Baltimore, Maryland, United States, 20723